Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 112
Filter
1.
J Phys Chem A ; 118(50): 11744-50, 2014 Dec 18.
Article in English | MEDLINE | ID: mdl-25420099

ABSTRACT

Bromoiodomethane, CH2BrI, is a molecule of natural origin emitted in significant amount into the marine boundary layer. It can easily be decomposed by solar radiation, releasing Br and I atoms in the troposphere, which in turn impacts the atmospheric chemistry. Spectroscopy is an invaluable tool to monitor species present in the atmosphere. Since no high-resolution spectroscopic studies are available for this dihalomethane, we have investigated the rotational spectra of the two bromine isotopologues of CH2BrI in its vibrational ground state in the microwave and millimeter-wave regions. Transitions of b-type have been recorded by Fourier transform microwave spectroscopy below 25 GHz while both a- and b-type spectral lines have been measured below 230 GHz. Observed transitions correspond to energy levels with J ≤ 132 and Ka ≤ 14. Molecular constants including those describing the nuclear quadrupole coupling tensors for (79)Br, (81)Br, and (127)I were accurately determined from the least-squares analysis of a total of 1873 distinct transition frequencies (of which 943 belong to the CH2(79)BrI isotopologue). An experimental (r0) structure of the title species has been derived from the two sets of rotational constants.

2.
J Chem Phys ; 132(2): 024310, 2010 Jan 14.
Article in English | MEDLINE | ID: mdl-20095677

ABSTRACT

Molecular pulsed jet, chirped-pulse Fourier transform microwave spectroscopy has been used to record 499 transitions for the title molecule. Measurements have been made in the 8-16 GHz regions. Vibrational and electronic ground state rotational constants A, B, and C have been obtained, together with centrifugal distortion terms. The complete iodine and nitrogen nuclear quadrupole coupling tensors have been determined for the first time. Quantum chemical calculations have been performed to aid with analyses and, in particular, to aid in determining the signs of the off-diagonal components of the nuclear quadrupole coupling tensors. An experimentally determined relative electronegativity scale for several polyhalomethyl groups is proposed.

3.
Thorax ; 63(4): 301-5, 2008 Apr.
Article in English | MEDLINE | ID: mdl-17951276

ABSTRACT

BACKGROUND: Cardiovascular disease is a major cause of death in patients with chronic obstructive pulmonary disease (COPD) and predicts hospitalisation for acute exacerbation, in-hospital death and post-discharge mortality. Although beta blockers improve cardiovascular outcomes, patients with COPD often do not receive them owing to concerns about possible adverse pulmonary effects. There are no published data about beta blocker use among inpatients with COPD exacerbations. A study was undertaken to identify factors associated with beta blocker use in this setting and to determine whether their use is associated with decreased in-hospital mortality. METHODS: Administrative data from the University of Alabama Hospital were reviewed and patients admitted between October 1999 and September 2006 with an acute exacerbation of COPD as a primary diagnosis or as a secondary diagnosis with a primary diagnosis of acute respiratory failure were identified. Demographic data, co-morbidities and medication use were recorded and subjects receiving beta blockers were compared with those who did not. Multivariate regression analysis was performed to determine predictors of in-hospital death after controlling for known covariates and the propensity to receive beta blockers. RESULTS: 825 patients met the inclusion criteria. In-hospital mortality was 5.2%. Those receiving beta blockers (n = 142) were older and more frequently had cardiovascular disease than those who did not. In multivariate analysis adjusting for potential confounders including the propensity score, beta blocker use was associated with reduced mortality (OR = 0.39; 95% CI 0.14 to 0.99). Age, length of stay, number of prior exacerbations, the presence of respiratory failure, congestive heart failure, cerebrovascular disease or liver disease also predicted in-hospital mortality (p<0.05). CONCLUSIONS: The use of beta blockers by inpatients with exacerbations of COPD is well tolerated and may be associated with reduced mortality. The potential protective effect of beta blockers in this population warrants further study.


Subject(s)
Adrenergic beta-Antagonists/therapeutic use , Pulmonary Disease, Chronic Obstructive/drug therapy , Acute Disease , Aged , Cardiovascular Diseases/complications , Female , Hospital Mortality , Humans , Length of Stay , Male , Neoplasms/complications , Pulmonary Disease, Chronic Obstructive/complications , Pulmonary Disease, Chronic Obstructive/mortality , Regression Analysis , Risk Factors , Treatment Outcome
4.
J Econ Entomol ; 98(6): 2013-9, 2005 Dec.
Article in English | MEDLINE | ID: mdl-16539127

ABSTRACT

Yield loss in soft red winter wheat, Triticum aestivum L., caused by aphid-transmitted barley yellow dwarf virus (family Luteoviridae, genus Luteovirus, BYDV) was measured over a 2-yr period in central Missouri. Rhopalosiphum padi (L.) was the most common and economically important species, accounting for > 90% of the total aphids. Schizaphis graminum (Rondani), Rhopalosiphum maidis (Fitch), and Sitobion avenae (F.) made up the remainder of the aphids. Aphid numbers peaked at wheat stem elongation in 2003 with 771 R. padi per meter-row. In the 2003-2004 growing season, aphid numbers averaged seven aphids per meter-row in the fall and peaked at 18 aphids per meter-row at jointing. Wheat grain yield was reduced 17 and 13% in 2003 and 2004, respectively. Thousand kernel weights were reduced 10 and 5% in the untreated plots compared with the treated control in 2003 and 2004, respectively. Padi avenae virus was the predominate strain, accounting for 81 and 84% of the symptomatic plots that tested positive for BYDV in 2003 and 2004. Our results indicate that economic thresholds for R. padi are 16 aphids per meter-row in the fall and 164 aphids per meter-row at jointing.


Subject(s)
Aphids/physiology , Luteovirus/isolation & purification , Triticum/parasitology , Triticum/virology , Animals , Aphids/drug effects , Imidazoles , Insect Control/economics , Insect Control/methods , Insecticides/economics , Insecticides/pharmacology , Neonicotinoids , Nitriles/economics , Nitriles/pharmacology , Nitro Compounds , Plant Diseases/parasitology , Plant Diseases/virology , Pyrethrins/economics , Pyrethrins/pharmacology , Time Factors , Triticum/economics , Triticum/genetics
5.
Int J Tuberc Lung Dis ; 7(12 Suppl 3): S369-74, 2003 Dec.
Article in English | MEDLINE | ID: mdl-14677825

ABSTRACT

SETTING: The State of Alabama Department of Public Health Division of Tuberculosis Control. OBJECTIVE: To standardize contact investigation protocols and implement an intervention to increase TB field worker adherence to the protocols with the goal of promoting efficiency and effectiveness in contact investigations. DESIGN: A process evaluation of existing data collection and management systems and protocols was performed. Standardized protocols and an intervention to increase TB field worker adherence to the protocols were created and pilot tested. These were then implemented and formative evaluation data were collected. RESULTS: The process evaluation revealed considerable variance among field workers with regard to protocols and definitions of variables related to contact investigations. Protocols were standardized and an intervention targeted at TB field workers was developed. The intervention consisted of a training workshop and the development of a computer-based contact investigation module. This was successfully implemented throughout the state. CONCLUSIONS: To perform effective contact investigations and conduct studies to improve the effectiveness of these investigations, TB control programs must pay careful attention to precisely defining variables and concepts related to the contact investigation. Furthermore, protocols must be standardized and resources devoted to training of TB field workers to ensure adherence to protocols.


Subject(s)
Contact Tracing , Guideline Adherence , Health Plan Implementation , Practice Guidelines as Topic/standards , Tuberculosis/prevention & control , Tuberculosis/transmission , Alabama , Humans , Outcome and Process Assessment, Health Care , Program Evaluation , Reference Standards
6.
Respir Med ; 96(6): 444-9, 2002 Jun.
Article in English | MEDLINE | ID: mdl-12117045

ABSTRACT

The use of FEV1/FEV6 in place of the traditional FEV1/FVC to detect airways obstruction during spirometry testing performed by primary care providers would reduce time and patient effort. We hypothesized that the FEV1/FEV6, would predict the subsequent decline in FEV1 in adult cigarette smokers who enrolled in the multicenter Lung Health Study. Ten clinical centers in the U.S. and Canada recruited 5887 male and female smokers, aged 35-60 years, with borderline to mild airways obstruction by spirometry. Those who successfully stopped smoking during the 5-yr study (usually as the result of the smoking cessation intervention) were excluded from this analysis. In those continuing to smoke, the relative strength of spirometric predictors of the change in FEV1 during 5 years of follow-up (DFEV1) was determined using a linear regression model. The following covariates were significant independent predictors of DFEV1: the baseline degree of airways obstruction, age, gender, cigarettes per day, years of education, and bronchial hyperresponsiveness. The FEV1/FEV6 was nearly as strong an independent predictor as was the FEV1/FVC (a traditional index of airways obstruction). The degree of airways obstruction, as determined by the FEV1/FEV6 from spirometry, is an independent predictor of subsequent decline in lung function; and therefore, may be used to detect smokers at higher risk of developing COPD.


Subject(s)
Pulmonary Disease, Chronic Obstructive/diagnosis , Smoking/adverse effects , Adult , Female , Follow-Up Studies , Forced Expiratory Volume/physiology , Humans , Male , Middle Aged , Pulmonary Disease, Chronic Obstructive/etiology , Respiratory Function Tests/methods , Vital Capacity/physiology
7.
J Cardiopulm Rehabil ; 21(5): 296-9, 2001.
Article in English | MEDLINE | ID: mdl-11591044

ABSTRACT

PURPOSE: Although physicians generally reserve pulmonary rehabilitation (PR) referral for patients in later stages of chronic obstructive pulmonary disease (COPD), there is no evidence to suggest that PR programs are more effective for these persons than for those in earlier stages of the disease. This study examined the relationship between 6-minute walk change and COPD stage in patients completing PR. METHODS: The sample consisted of 76 patients who enrolled in the University of Alabama at Birmingham's Cardiopulmonary Rehabilitation Program with a primary diagnosis of COPD between January 1996 and June 2000. Data was collected on 6-minute walk upon entry into the program and upon program completion. Patients were stratified according to COPD stage using the American Thoracic Society staging system. RESULTS: There were significant differences among the three stages with regard to initial and ending 6-minute walk distances such that persons in later stages of the disease have shorter initial and ending 6-minute walk distances. However, all three stages show significant improvements in the 6-minute walk after PR. There were no significant differences in the median change among groups indicating that the median change was not better (or worse) for patients in any particular COPD stage. CONCLUSIONS: This study suggests that PR is equally effective in increasing physical performance for all patients regardless of COPD stage. This type of information can be used to support the recommendation of PR for patients early in the disease process.


Subject(s)
Pulmonary Disease, Chronic Obstructive/rehabilitation , Walking , Aged , Alabama/epidemiology , American Medical Association/organization & administration , Female , Health Planning/standards , Humans , Male , Middle Aged , Practice Guidelines as Topic , Severity of Illness Index , Statistics, Nonparametric , Treatment Outcome , United States/epidemiology , Walking/statistics & numerical data
10.
Am J Respir Crit Care Med ; 161(2 Pt 1): 381-90, 2000 Feb.
Article in English | MEDLINE | ID: mdl-10673175

ABSTRACT

Previous studies of lung function in relation to smoking cessation have not adequately quantified the long-term benefit of smoking cessation, nor established the predictive value of characteristics such as airway hyperresponsiveness. In a prospective randomized clinical trial at 10 North American medical centers, we studied 3, 926 smokers with mild-to-moderate airway obstruction (3,818 with analyzable results; mean age at entry, 48.5 yr; 36% women) randomized to one of two smoking cessation groups or to a nonintervention group. We measured lung function annually for 5 yr. Participants who stopped smoking experienced an improvement in FEV(1) in the year after quitting (an average of 47 ml or 2%). The subsequent rate of decline in FEV(1) among sustained quitters was half the rate among continuing smokers, 31 +/- 48 versus 62 +/- 55 ml (mean +/- SD), comparable to that of never-smokers. Predictors of change in lung function included responsiveness to beta-agonist, baseline FEV(1), methacholine reactivity, age, sex, race, and baseline smoking rate. Respiratory symptoms were not predictive of changes in lung function. Smokers with airflow obstruction benefit from quitting despite previous heavy smoking, advanced age, poor baseline lung function, or airway hyperresponsiveness.


Subject(s)
Lung Diseases, Obstructive/rehabilitation , Lung Volume Measurements , Smoking Cessation , Adult , Airway Resistance/physiology , Bronchial Provocation Tests , Bronchodilator Agents/administration & dosage , Combined Modality Therapy , Female , Follow-Up Studies , Forced Expiratory Volume/drug effects , Forced Expiratory Volume/physiology , Humans , Ipratropium/administration & dosage , Lung Diseases, Obstructive/etiology , Lung Diseases, Obstructive/physiopathology , Male , Middle Aged , Smoking/adverse effects , Smoking/physiopathology , Treatment Outcome , Vital Capacity/drug effects , Vital Capacity/physiology
11.
J Cardiopulm Rehabil ; 20(6): 340-5, 2000.
Article in English | MEDLINE | ID: mdl-11144039

ABSTRACT

PURPOSE: Advance directives have been available in parts of the United States for more than 20 years, but research shows that only a small percentage of adults (5-25%) have some form of written advance directive. The purose of this study was to examine the presence of advance directives among persons entering cardiac and pulmonary rehabilitation, and identify characteristics of persons most likely to have advance directives. METHODS: The sample consisted of 336 cardiac patients and 181 pulmonary patients who enrolled in the University of Alabama at Birmingham's Cardiopulmonary Rehabilitation Program between January 1996 and December 1999. As part of the initial program assessment, patients were asked two questions: (1) Do you have a living will? (2) Do you have any advance directives? For the purposes of this study, the two questions were combined to examine the presence of either a living will or other type of advance directive. RESULTS: Results indicate that 25% of both subgroups (cardiac and pulmonary patients) report having written advance directives. Logistic regression analysis indicates that among cardiac patients whites and older persons were more likely to have advance directives. Among pulmonary patients, females and whites were more likely to have advance directives. CONCLUSIONS: These results indicate that only a minority of cardiopulmonary rehabilitation patients have advance directives upon entry into the program, and that the prevalence differs among gender, racial, and age groups. Cardiac and pulmonary rehabilitation programs may be valuable sites for educating patients about advance directives and efforts by rehabilitation personnel may increase the prevalence of advance directives among patients.


Subject(s)
Advance Directives/statistics & numerical data , Heart Diseases , Respiratory Tract Diseases , Adult , Aged , Aged, 80 and over , Alabama , Female , Heart Diseases/rehabilitation , Humans , Logistic Models , Male , Middle Aged , Prospective Studies , Respiratory Tract Diseases/rehabilitation
12.
Allergy Asthma Proc ; 20(3): 181-8, 1999.
Article in English | MEDLINE | ID: mdl-10389551

ABSTRACT

The purpose of this study was to demonstrate that a simple submaximal "step-test" could be used as an exercise challenge to identify elementary school students with suspected but undiagnosed asthma. This article also describes a protocol for exercise testing that can be used in epidemiological evaluations. School age children grades 1-4 with suspected but undiagnosed asthma were identified by a 12-item questionnaire completed by a parent or guardian. Only students identified with suspected asthma by questionnaire were exercise challenged on a step-test it baseline spirometry was normal and there was no contraindication for intense aerobic activity. Possible asthma was defined as a 15% or greater decrease in FEV1 or a 25% or greater decrease in FEF25-75 from baseline at either 3 or 10 minutes. The exercise protocol included spirometry before and after stepping continuously for 5 minutes at an exercise intensity sufficient to maintain a heart rate between 150 and 200 beats per minute. Heart rate was continuously monitored throughout the exercise period. Testing was completed at school. No complications occurred during the exercise testing. Exercise testing was completed on 548 students with suspected undiagnosed asthma. Thirty students (6%) had exercise test changes in pulmonary function that met established criteria for suspecting asthma. A board-certified pediatric allergist/immunologist or private physician examined 26 of the 30 students with positive exercise testing. Asthma was diagnosed in 23 (88.89%) of these students. All students with impaired pulmonary function after exercise were able to return to class after a short period of observation. In conclusion, a simple, reproducible school-based exercise protocol can be used to identify students with suspected undiagnosed asthma.


Subject(s)
Asthma, Exercise-Induced/diagnosis , Exercise Test/methods , Bronchospirometry , Child , Female , Forced Expiratory Volume , Heart Rate , Humans , Male , Reproducibility of Results , Surveys and Questionnaires
13.
Arch Intern Med ; 159(20): 2422-8, 1999 Nov 08.
Article in English | MEDLINE | ID: mdl-10665890

ABSTRACT

BACKGROUND: During the past 15 years, programs to improve self-management practices in adults with asthma have reported improvement in functional status and reduction of inappropriate use of health care services. However, these programs usually represent an ideal approach, applying multiple patient education methods. Consequently, when these programs are found to be efficacious, it is important to replicate the programs as well as to evaluate less complex methods that may be more appropriate for nonacademic health care settings. METHODS: We compared the following 3 standardized self-management treatments in a randomized, controlled trial: (1) a replication of the self-management program developed at a university medical center that was previously shown to be efficacious; (2) a modified version of this program including only the core elements; and (3) a usual-care program. Outcome measures included medication and inhaler regimen adherence, asthma symptoms, respiratory illness, functional status, and use of health care resources. RESULTS: All 3 groups improved on measures of respiratory illnesses, use of health care services, and functional status. Patients in both education groups did no better than the usual-care group. CONCLUSIONS: The results are inconsistent with the results of the first asthma self-management study at this institution and with those of efficacy studies of similar programs. Two factors, selection of the patient population and historical changes in asthma treatment, most likely contributed to the lack of impact of the self-management programs. As a result of the improved standards for usual care due to both factors, the opportunity to effect patient outcomes was substantially reduced.


Subject(s)
Asthma/therapy , Patient Education as Topic , Self Care , Administration, Inhalation , Adult , Anti-Asthmatic Agents/administration & dosage , Asthma/complications , Asthma/physiopathology , Female , Focus Groups , Health Resources/statistics & numerical data , Humans , Male , Multivariate Analysis , Outcome Assessment, Health Care , Patient Selection , Program Evaluation , Respiratory Tract Diseases/complications , Time Factors , United States
14.
J Am Diet Assoc ; 98(8): 885-8, 1998 Aug.
Article in English | MEDLINE | ID: mdl-9710658

ABSTRACT

OBJECTIVE: To survey dietitians in health care facilities about the acceptability of alternative meat and poultry processing methods designed to reduce the risk of foodborne disease and their willingness to pay for these processes. SUBJECTS: A geographically representative sample of 600 members of The American Dietetic Association who work in health care facilities. The response rate was 250 completed questionnaires from 592 eligible subjects (42%). DESIGN: A mail survey was used to gather information on the acceptability of a Hazard Analysis and Critical Control Point (HACCP) system, chemical rinses, and irradiation for increasing the safety of food. Discrete choice contingent valuation was used to determine the acceptability at current prices and at 5, 10, and 25 cents per pound above current prices. STATISTICAL ANALYSES: Logistic regression was used to estimate mean willingness to pay (the maximum amount respondents are willing to pay) for each process. A simultaneous equations regression model was used to estimate the effects of other variables on acceptability. RESULTS: Respondents expressed a high level of concern for food safety in health care facilities. The estimated mean willingness to pay was highest for a HACCP system and lowest for chemical rinses. CONCLUSIONS/APPLICATIONS: The successful adoption of alternative methods to increase food safety depends on their acceptance by foodservice professionals. The professionals sampled were most accepting of a HACCP system, somewhat less accepting of irradiation, and least accepting of new chemical rinses. Poultry and beef processors and government agencies concerned with food safety may want to take into account the attitudes of foodservice professionals.


Subject(s)
Dietetics , Food Handling/standards , Foodborne Diseases/prevention & control , Meat/standards , Animals , Cattle , Data Collection , Disinfection/methods , Food Inspection/methods , Food Irradiation , Humans , Poultry Products/standards , Risk Factors
16.
Chest ; 110(6): 1379-81, 1996 Dec.
Article in English | MEDLINE | ID: mdl-8989046
17.
Chest ; 109(2): 438-45, 1996 Feb.
Article in English | MEDLINE | ID: mdl-8620719

ABSTRACT

STUDY OBJECTIVE: To assess cardiovascular conditions and other side effects associated with the use of nicotine polacrilex (NP), 2 mg. DESIGN: A multicentered randomized control trial of early intervention for the prevention of COPD. SETTING: Ten university medical centers in the United States and Canada. PARTICIPANTS: Adult smoking volunteers with evidence of early COPD; 3,923 in intervention and 1,964 controls. INTERVENTION: Smoking cessation program, including NP. MEASUREMENTS: Data on hospitalizations were collected annually. Data on reported NP side effects were collected at 4-month intervals for intervention participants. RESULTS: The rates of hospitalization for cardiovascular conditions and cardiovascular deaths during the 5 years of the study were not related to use of NP, to dose of NP, or to concomitant use of NP and cigarettes. About 25% of NP users reported at least one side effect, but most were very minor and transient. Side effects associated with discontinuance of NP in 5% or more of users included headache, indigestion, mouth irritation, mouth ulcers, and nausea. There was no evidence that concomitant use of NP and cigarettes was associated with elevated rates of reported side effects. Participants in the smoking cessation intervention who received intensive levels of instruction and monitoring of NP use (initially at 12 meetings during 3 months) appeared to report significantly lower rates of side effects (dizziness, headache, and throat irritation) than control participants, presumed to have less instruction and monitoring. CONCLUSIONS: NP, as used in the Lung Health Study, appears to be safe and unrelated to any cardiovascular illnesses or other serous side effects.


Subject(s)
Cardiovascular Diseases/etiology , Chewing Gum/adverse effects , Nicotine/analogs & derivatives , Polymethacrylic Acids/adverse effects , Polyvinyls/adverse effects , Smoking Cessation , Adult , Bronchodilator Agents/therapeutic use , Cardiovascular Diseases/complications , Female , Hospitalization , Humans , Ipratropium/therapeutic use , Lung Diseases, Obstructive/complications , Lung Diseases, Obstructive/prevention & control , Male , Middle Aged , Nicotine/adverse effects , Randomized Controlled Trials as Topic , Tobacco Use Cessation Devices
18.
Curr Opin Pulm Med ; 2(1): 16-22, 1996 Jan.
Article in English | MEDLINE | ID: mdl-9363110

ABSTRACT

We review recently published literature on behavioral aspects of asthma, including program descriptions, reviews, and original research reports. Most of the literature on behavioral aspects of asthma has been in the area of self-management, including education, medication use, and peak flow monitoring. Recent studies of these factors have shown promising trends in reducing morbidity and in improving health care utilization outcomes. Medication adherence continues to be problematic, and its complexity is increased when comparing inhaled with oral medications and bronchodilators with anti-inflammatory agents. Psychobiologic factors that have been recently studied include perceptions of airway changes and the role of emotional responses in asthma self-management. Because the behavioral aspects of asthma play such a significant role in asthma treatment, further study is needed to determine how changes in patient behavior can improve patient quality of life.


Subject(s)
Asthma/psychology , Health Behavior , Self Care , Administration, Inhalation , Administration, Oral , Anti-Asthmatic Agents/administration & dosage , Anti-Asthmatic Agents/therapeutic use , Anti-Inflammatory Agents/administration & dosage , Anti-Inflammatory Agents/therapeutic use , Asthma/drug therapy , Asthma/therapy , Bronchial Hyperreactivity/psychology , Bronchodilator Agents/administration & dosage , Bronchodilator Agents/therapeutic use , Emotions , Humans , Monitoring, Physiologic , Patient Compliance , Patient Education as Topic , Peak Expiratory Flow Rate , Psychophysiologic Disorders/psychology , Quality of Life , Treatment Outcome
19.
Clin Chest Med ; 16(4): 557-65, 1995 Dec.
Article in English | MEDLINE | ID: mdl-8565400

ABSTRACT

Given that poor asthma management leads to such devastating rates of morbidity and mortality in this country, efforts must be made to increase the knowledge, skills, and behaviors of persons with asthma. The suggestions and recommendations provided here represent a blend of academic opinion and practical advice on methods to implement an asthma education program. In developing an asthma education program, consideration must be given to what content should be included, how and by whom that content should be taught, and when education should take place. The identification of a key clinical staff member to take the lead in translating these and other asthma education guidelines will be a critical next step for clinicians committed to developing an effective asthma education program.


Subject(s)
Asthma/therapy , Patient Education as Topic , Humans , Parents/education , Patient Education as Topic/methods
20.
JAMA ; 272(19): 1497-505, 1994 Nov 16.
Article in English | MEDLINE | ID: mdl-7966841

ABSTRACT

OBJECTIVE: To determine whether a program incorporating smoking intervention and use of an inhaled bronchodilator can slow the rate of decline in forced expiratory volume in 1 second (FEV1) in smokers aged 35 to 60 years who have mild obstructive pulmonary disease. DESIGN: Randomized clinical trial. Participants randomized with equal probability to one of the following groups: (1) smoking intervention plus bronchodilator, (2) smoking intervention plus placebo, or (3) no intervention. SETTING: Ten clinical centers in the United States and Canada. PARTICIPANTS: A total of 5887 male and female smokers, aged 35 to 60 years, with spirometric signs of early chronic obstructive pulmonary disease. INTERVENTIONS: Smoking intervention: intensive 12-session smoking cessation program combining behavior modification and use of nicotine gum, with continuing 5-year maintenance program to minimize relapse. Bronchodilator: ipratropium bromide prescribed three times daily (two puffs per time) from a metered-dose inhaler. MAIN OUTCOME MEASURES: Rate of change and cumulative change in FEV1 over a 5-year period. RESULTS: Participants in the two smoking intervention groups showed significantly smaller declines in FEV1 than did those in the control group. Most of this difference occurred during the first year following entry into the study and was attributable to smoking cessation, with those who achieved sustained smoking cessation experiencing the largest benefit. The small noncumulative benefit associated with use of the active bronchodilator vanished after the bronchodilator was discontinued at the end of the study. CONCLUSIONS: An aggressive smoking intervention program significantly reduces the age-related decline in FEV1 in middle-aged smokers with mild airways obstruction. Use of an inhaled anticholinergic bronchodilator results in a relatively small improvement in FEV1 that appears to be reversed after the drug is discontinued. Use of the bronchodilator did not influence the long-term decline of FEV1.


Subject(s)
Ipratropium/therapeutic use , Lung Diseases, Obstructive/prevention & control , Lung Diseases, Obstructive/physiopathology , Smoking Cessation , Administration, Inhalation , Adult , Analysis of Variance , Bronchodilator Agents/administration & dosage , Bronchodilator Agents/therapeutic use , Clinical Protocols/standards , Female , Follow-Up Studies , Forced Expiratory Volume , Humans , Ipratropium/administration & dosage , Linear Models , Lung Diseases, Obstructive/drug therapy , Male , Middle Aged , Models, Statistical , Patient Compliance , Patient Selection , Quality Control , Smoking/physiopathology , Spirometry
SELECTION OF CITATIONS
SEARCH DETAIL
...